Effect of imatinib on male reproductive hormones in BCR-ABL positive CML patients: A preliminary report. [electronic resource]
- Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners Aug 2014
- 243-8 p. digital
Publication Type: Journal Article
1477-092X
10.1177/1078155213500686 doi
Adolescent Adult Antineoplastic Agents--therapeutic use Humans Imatinib Mesylate--therapeutic use Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy Male Middle Aged Prospective Studies Young Adult